News Website

Over 80% of women have had their pain dismissed by a healthcare professional - MSN

Over 80% of women have had their pain dismissed by a healthcare professional MSN

Published: Oct. 28, 2024, 1:11 p.m.

Read Full Article

‘Medical misogyny’ nightmare called out - news.com.au

‘Medical misogyny’ nightmare called out news.com.au

Published: Oct. 28, 2024, 12:18 p.m.

Read Full Article

Women with Endometriosis Often Miss School and Work Due to Pain - Pain News Network

Women with Endometriosis Often Miss School and Work Due to Pain Pain News Network

Published: Oct. 28, 2024, 7:01 a.m.

Read Full Article

A Commentary on "Acupuncture and Related Therapies for Endometriosis: A Network Meta-Analysis of Randomised Controlled Trials" [Letter].

Published: Oct. 28, 2024, midnight

Read Full Article

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse

Published: Oct. 25, 2024, 5:14 a.m.

Read Full Article

Natural compounds for endometriosis and related chronic pelvic pain: A review.

Endometriosis is a chronic gynecological disorder characterized by significant chronic pelvic pain (CPP) and infertility, adversely affecting the quality of life for many women worldwide. This review aims to synthesize …

Published: Oct. 25, 2024, midnight

Read Full Article

Chronic pelvic pain Endometriosis Natural product Nutraceutical Phytotherapy

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.

Read Full Article

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.

Read Full Article

Characterization of E-Cadherin, SSEA-1, MSI-1, and SOX-2 Expression and Their Association with Pale Cells in Adenomyosis.

Adenomyosis (AM) is a gynecological disease characterized by the invasion of endometrial glands and stroma within the myometrium. The etiology and pathogenesis of AM remain inadequately understood. Pale cells were …

Published: Oct. 24, 2024, midnight

Read Full Article

E-cadherin MSI-1 SOX-2 SSEA-1 adenomyosis pale cell

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.

Read Full Article

Latest Articles

Over 80% of women have had their pain dismissed by a healthcare professional - MSN

‘Medical misogyny’ nightmare called out - news.com.au

Women with Endometriosis Often Miss School and Work Due to Pain - Pain News Network

A Commentary on "Acupuncture and Related Therapies for Endometriosis: A Network Meta-Analysis of Randomised Controlled Trials" [Letter].

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse

Natural compounds for endometriosis and related chronic pelvic pain: A review.

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Characterization of E-Cadherin, SSEA-1, MSI-1, and SOX-2 Expression and Their Association with Pale Cells in Adenomyosis.

ASCO Reading Room | Alessandro Santin, MD, on a Promising ADC for Refractory Endometrial Cancer - Medpage Today

Subscribe to Our Newsletter